Ilan Gabriely is an Endocrinology/Metabolic physician. OpenAlex indexes 51 publications with 2,888 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1991 State Hill Rd
Wyomissing, PA 196101648
Telephone
484-628-4270Provider last certified this registry record 5 Dec 2022.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
65.5%l-Thyroxine49.8%Levothyroxine Sodium75%Synthroid25%Part D≥111 patientsThyroid Hormone Synthesis Inhibitor12.7%Methimazole100%Part D≥39 patients+ 2 more classes in this area
Metabolism & gastrointestinal
22.1%Biguanide (metformin)7.2%Metformin Hcl87%Metformin Hcl Er13%Part D<11 patientsInsulin Analog5.3%Lantus Solostar49%Lantus18%Insulin Lispro Kwikpen U-10018%Novolog Flexpen15%Part D<11 patients+ 5 more classes in this area
Sensory organs
6.2%Corticosteroid6.2%Hydrocortisone100%Part D≥16 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- MON-158 Primary Hyperparathyroidism in Pregnancy: Parathyroidectomy in the Third Trimester
Journal of the Endocrine Society
2025 - MON-010 Immune Checkpoint Inhibitor-Associated Hypophysitis and Hormonal Deficiency
Journal of the Endocrine Society
2025 - Effects of Intranasal Naloxone on Hypoglycemia-associated Autonomic Failure in Susceptible Individuals
The Journal of Clinical Endocrinology & Metabolism
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”